The tool, he said: "provides consistent and unbiased insights previously unavailable that embryologists and physicians can use to make more informed decisions and offer transparency to prospective parents on their embryos".
Chloe is being used by clinicians at IVF London, the Harley Street Fertility Clinic, and the Centre for Reproductive and Genetic Health, and by practices in Spain, Turkey, Greece and Norway.
"Implementing AI technologies entering the IVF space challenges traditional norms and drives innovation forward for the entire industry," said Suzanne Cawood, director of embryology at CRGH.
“Fairtility's AI makes IVF more efficient and accessible to the growing population of people seeking fertility treatment."
One in six people worldwide experiences infertility in their reproductive years, according to the World Health Organisation.